Sign in to view content

Two-Year Results of an Ongoing Phase 1b/2 Open-Label Clinical Trial of AU-011 for the Primary Treatment of Small to Medium Choroidal Melanoma

Amy C. Schefler, MD FACS FASRS

Video
Published 2019

Amy C. Schefler, MD

Ocular Oncology Symposium

Related

Medical Case Conference: Scott Walter, MD, MSc, FASRS
Scott D Walter, MD, MSc, FASRS
Annual Meeting Talks
2024
Silicone Oil (SO) Microdroplets in Repackaged Bevacizumab Syringes: Identification, Quantification, and Strategies For Reducing Clincal Impact
John D Pitcher, MD
On Demand Cases, Courses, and Papers
2017
Impact of PRAME Status on Gene Expression Profile to Predict Metastasis in Uveal Melanoma: Interim Analysis of the Collaborative Ocular Oncology Group Study Number 2 (COOG2)
Prithvi Mruthyunjaya, MD, MHS
Updates from the Field
2022

Category: Ocular Oncology

See more